Browse > Article
http://dx.doi.org/10.3340/jkns.2016.0809.002

Significant Risk Factors for Postoperative Enlargement of Basal Ganglia Hematoma after Frameless Stereotactic Aspiration : Antiplatelet Medication and Concomitant IVH  

Son, Wonsoo (Department of Neurosurgery, Kyungpook National University School of Medicine)
Park, Jaechan (Department of Neurosurgery, Kyungpook National University School of Medicine)
Publication Information
Journal of Korean Neurosurgical Society / v.60, no.5, 2017 , pp. 591-596 More about this Journal
Abstract
Objective : Frameless stereotactic aspiration of a hematoma can be the one of the treatment options for spontaneous intracerebral hemorrhage in the basal ganglia. Postoperative hematoma enlargement, however, can be a serious complication of intracranial surgery that frequently results in severe neurological deficit and even death. Therefore, it is important to identify the risk factors of postoperative hematoma growth. Methods : During a 13-year period, 101 patients underwent minimally invasive frameless stereotactic aspiration for basal ganglia hematoma. Patients were classified into two groups according to whether or not they had postoperative hematoma enlargement in a computed tomography scan. Baseline demographic data and several risk factors, such as hypertension, preoperative hematoma growth, antiplatelet medication, presence of concomitant intraventricular hemorrhage (IVH), were analysed via a univariate statistical study. Results : Nine of 101 patients (8.9%) showed hematoma enlargement after frameless stereotactic aspiration. Among the various risk factors, concomitant IVH and antiplatelet medication were found to be significantly associated with postoperative enlargement of hematomas. Conclusion : In conclusion, our study revealed that aspirin use and concomitant IVH are factors associated with hematoma enlargement subsequent to frameless stereotactic aspiration for basal ganglia hematoma.
Keywords
Stereotactic techniques; Suction; Basal ganglia hemorrhage; Risk factors;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al. : Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet 365 : 387-397, 2005   DOI
2 Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM; STICH II Investigators : Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet 382 : 397-408, 2013   DOI
3 Baharoglu MI, Cordonnier C, Al-Shahi Salman R, de Gans K, Koopman MM, Brand A, et al. : Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (Patch): a randomised, open-label, rhase 3 trial. Lancet 387 : 2605-2613, 2016   DOI
4 Broderick JP, Diringer MN, Hill MD, Brun NC, Mayer SA, Steiner T, et al. : Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke 38 : 1072-1075, 2007   DOI
5 Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al. : Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28 : 1-5, 1997   DOI
6 Palmer JD, Sparrow OC, Iannotti F : Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery 35 : 1061-1064; discussion 1064-1065, 1994   DOI
7 Montes JM, Wong JH, Fayad PB, Awad IA : Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma : protocol and preliminary experience. Stroke 31 : 834-840, 2000   DOI
8 Morgenstern LB, Demchuk AM, Kim DH, Frankowski RF, Grotta JC : Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology 56 : 1294-1299, 2001   DOI
9 Naidech AM, Jovanovic B, Liebling S, Garg RK, Bassin SL, Bendok BR, et al. : Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke 40 : 2398-2401, 2009   DOI
10 Rand ML, Leung R, Packham MA : Platelet function assays. Transfus Apher Sci 28 : 307-317, 2003   DOI
11 Kawamata T, Takeshita M, Kubo O, Izawa M, Kagawa M, Takakura K : Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol 44 : 438-442; discussion 443, 1995   DOI
12 Fujii Y, Tanaka R, Takeuchi S, Koike T, Minakawa T, Sasaki O : Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg 80 : 51-57, 1994   DOI
13 Creutzfeldt CJ, Weinstein JR, Longstreth WT Jr., Becker KJ, McPharlin TO, Tirschwell DL : Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage. J Stroke Cerebrovasc Dis 18 : 221-228, 2009   DOI
14 el Chami B, Milan C, Giroud M, Sautreaux JL, Faivre J : Intracerebral hemorrhage survival: French register data. Neurol Res 22 : 791-796, 2000   DOI
15 Engel-Haber E, Horev A, Chablani P, Bornstein NM, Jadhav A, Jovin TG, et al. : Aspirin response test role in platelet transfusion following intracerebral hemorrhage. Clin Neurol Neurosurg 137 : 12-14, 2015   DOI
16 Suzuki Y, Kitahara T, Soma K, Konno S, Sato K, Suzuki S, et al. : Impact of platelet transfusion on survival of patients with intracerebral hemorrhage after administration of anti-platelet agents at a tertiary emergency center. PLoS One 9 : e97328, 2014   DOI
17 Xu F, Tang Z, Luo X, Kang H, Hu Q, Wang W, et al. : No evidence of preoperative hematoma growth representing an increased postoperative rebleeding risk for minimally invasive aspiration and thrombolysis of ICH. Br J Neurosurg 24 : 268-274, 2010
18 Engelhard HH, Andrews CO, Slavin KV, Charbel FT : Current management of intraventricular hemorrhage. Surg Neurol 60 : 15-21; discussion 21-22, 2003   DOI
19 Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R : Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 29 : 1160-1166, 1998   DOI
20 Hallevi H, Albright KC, Aronowski J, Barreto AD, Martin-Schild S, Khaja AM, et al. : Intraventricular hemorrhage: anatomic relationships and clinical implications. Neurology 70 : 848-852, 2008   DOI
21 Karnik R, Valentin A, Ammerer HP, Hochfelner A, Donath P, Slany J : Outcome in patients with intracerebral hemorrhage: predictors of survival. Wien Klin Wochenschr 112 : 169-173, 2000
22 Zuccarello M, Brott T, Derex L, Kothari R, Sauerbeck L, Tew J, et al. : Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke 30 : 1833-1839, 1999   DOI
23 Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. : Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 46 : 2032-2060, 2015   DOI
24 Ishibashi A, Yokokura Y, Adachi H : Is antiplatelet therapy for the prevention of ischemic stroke associated with the prognosis of intracerebral hemorrhage? Kurume Med J 55 : 71-75, 2008   DOI
25 Juvela S : Risk factors for impaired outcome after spontaneous intracerebral hemorrhage. Arch Neurol 52 : 1193-1200, 1995   DOI
26 Kaneko M, Tanaka K, Shimada T, Sato K, Uemura K : Long-term evaluation of ultra-early operation for hypertensive intracerebral hemorrhage in 100 cases. J Neurosurg 58 : 838-842, 1983   DOI